Filing Details
- Accession Number:
- 0001562180-19-002012
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-22 16:05:42
- Reporting Period:
- 2019-03-21
- Accepted Time:
- 2019-03-22 16:05:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1395937 | Syndax Pharmaceuticals Inc | SNDX | Pharmaceutical Preparations (2834) | 320162505 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1664204 | L. Michael Meyers | C/O Syndax Pharmaceuticals, Inc. 35 Gatehouse Drive, Building D, Floor 3 Waltham MA 02451 | Svp, Chief Medical Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-03-21 | 1,000 | $4.93 | 7,118 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-03-21 | 104 | $4.87 | 7,222 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |